Official Symbol: CNR1provided by HGNC
Official Full Name: cannabinoid receptor 1 (brain)provided by HGNC
Primary Source: HGNC:2159
Locus Tag: RP1-23D17.1
See related: Ensembl:ENSG00000118432; HPRD:00259; MIM:114610
Gene type: protein coding
RefSeq status: REVIEWED
Organism: Homo sapiens
Lineage: Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
Also known as: CB1; CNR; CB-R; CB1A; CB1R; CANN6; CB1K5; CNR1
Summary: This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene. [provided by RefSeq]

[Top][Help]Genomic regions, transcripts, and products

(minus strand) Go to reference sequence details Try our new Sequence Viewer

[Top][Help]Genomic context

chromosome: 6; Location: 6q14-q15See CNR1 in MapViewer

[Top][Help]Bibliography

GeneRIFs: Gene References Into Function What's a GeneRIF?

	1.	Case-control analysis identified a nominal association between single nucleotide polymorphism of CNR1 and having one or more cannabis dependence symptoms
	2.	Very low or absent FAAH and high CB1 levels correspond with spontaneous miscarriage.
	3.	Our results demonstrated a significant haplotypic effect of CNR1 on migraine headaches.
	4.	The loss of CB(1) receptors in HD is also thought to be a compensatory mechanism due to evidence that endocannabinoids modulate the reuptake of GABA in the GP.
	5.	A role for the cannabinoid receptor 1 gene in cannabis dependence.
	6.	results demonstrate the expression and regulation of CB1 and CB2 receptors and fatty acid amide hydrolase in retinal pigment epithelial cells
	7.	The results represent the first evidence in humans that the CNR1 gene is a risk factor for depression through a high neuroticism and low agreeableness phenotype.
	8.	results suggest that spinal endocannabinoids and CB1 receptors on inhibitory dorsal horn interneurons act as mediators of heterosynaptic pain sensitization and play an unexpected role in dorsal horn pain-controlling circuits
	9.	Circular dichroism (CD) spectroscopy revealed that a peptide corresponding to the full-length C-tail of the human CB1 receptor adopts an alpha-helical conformation in negatively charged and zwitterionic detergents.
	10.	Synthetic CB1 peptide backbone dynamics and rotameric freedom are altered by the peptide's phospholipid bilayer environment, which exerts a dynamic influence on the conformation of a transmembrane helix critical to signal transmission by the CB1 receptor.
	11.	CB1 helices 7 and 8 reconstituted into phospholipid bilayers are oriented in a transmembrane and in-plane (i.e., parallel to the phospholipid membrane surface) fashion, respectively.
	12.	We conclude that two independent CNR1 variants have significant interaction effects on risk for cocaine dependence (CD) in European-Americans; they may also have effects on risk for CD in African-Americans.
	13.	CB1R system may play a role in the development of insulin resistance in human skeletal muscle.
	14.	Higher CB(1) receptor expression was associated with lower scores in several eating disorder inventory-2 subscales including perfectionism, impulse regulation and drive for thinness, indicating impaired endocannabinoid signaling in eating disorders.
	15.	a single nucleotide mutation in CNR1 has a role in colorectal cancer outcome
	16.	There is no evidence for an association of common variants in the CNR1 and FAAH genes with measures of adiposity.
	17.	there was a high frequency of G --> A mutation in the CNR1 gene in patients with esophageal cancer.
	18.	Increase in genetic expression serve as a prognostic factor in prostate cancer.
	19.	These results suggest that CB1 receptors acting through the phosphorylation of ERK are involved not only in the extinction of conditioned fear but also in the adaptation to aversive situations in general.
	20.	Overweight patients and those with metabolic syndrom X show an expression pattern supporting a CB1-mediated overactivity of the endocannabinoid system in human visceral adipose tissue.
	21.	A common CNR1 haplotype (H4; prevalence 0.132) is associated with abnormal lipid homeostasis.
	22.	Reduced mRNA expression along with a possible association between polymorphism genotypes of the CNR1 gene and ectopic pregnancy, suggests a possible genetic predisposition to ectopic pregnancy.
	23.	we did not find substantial difference among the three variants human cannabinoid CB(1) receptor according to the binding affinity, functional potency, and efficacy
	24.	fibroblast-like synoviocytes of knees of rheumatoid arthritis and osteoarthritis patients express cannabinoid receptor (CB)1 and CB2
	25.	Patients with coronary artery disease demonstrated the activation of the endocannabinoid system with elevated levels of blood endocannabinoids and increased expression of CB1 receptor in coronary atheroma
	26.	mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis.
	27.	Association of CNR1 with ADHD and post-traumatic stress disorder is reported.
	28.	The CNR1 SNP displayed a significant abstinence x genotype interaction on withdrawal, as well as a main effect on overall levels of craving, while the FAAH SNP displayed a significant abstinence x genotype interaction on craving.
	29.	temporal-spatial expression of FAAH, CB1, and CB2 is regulated during early pregnancy and anandamide detrimentally alters trophoblast proliferation
	30.	CNR1 gene polymorphism is associated with central obesity in this Brazilian population of European ancestry
	31.	down-regulation of survivin by CB1 is mediated by a cyclic AMP-dependent protein kinase A signaling pathway
	32.	CNR1 gene is related to alcohol dependence.
	33.	CNR1 gene assosiated with nicotine dependence
	34.	reduced cortical cannabinoid 1 receptor messenger RNA found in schizophrenia.
	35.	This study indicates that the local cellular environment affects the structural determinants of CB(1)R internalization. Additionally, phosphorylation likely regulates the internalization of (full-length) CB(1)Rs.
	36.	Intracellular CB(1) receptors are functional and their spatial segregation is likely to significantly affect receptor function.
	37.	Schizophrenic subjects with prominent lifetime scores for disorganization and negative symptoms (dimension for hebephrenia) are associated with the CNR1 gene and present a type of symptomatology that resembles chronic cannabinoid-induced psychosis
	38.	The upregulation of CB1 in activated T cells enables cellular responses to cannabinoids
	39.	CNR1 variations increase the risk for obesity and modulate body mass index in European population.
	40.	Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
	41.	LH-21 is a low affinity inverse agonist for the CB1 receptor.
	42.	impaired CB1 receptor function promotes passive stress-coping behavior, which, at least in part, might relate to alterations in BDNF function.
	43.	cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development
	44.	No associations were identified between CNR1 genetic variants and cognitive impairment in multiple sclerosis
	45.	Genes such as ELTD1 on chromosome 1, in addition to genes on chromosomes 4 (eg, GABRA2) and 6 (eg, CNR1), may be associated with the genetic risk for cannabis use disorders.
	46.	it is the constitutive activity inherent in the cannabinoid CB1 receptor that reduces the capacity of co-expressed mu opioid receptor to function
	47.	CB(1) receptors are present in the gastric epithelium of the mucosa
	48.	AEA is able to decrease differentiating gene expression by increasing DNA methylation in human keratinocytes, through a p38, and to a lesser extent p42/44, mitogen-activated protein kinase-dependent pathway triggered by CB1R.
	49.	CB1 is densely located in glucagon-secreting alpha cells and less so in insulin-secreting beta cells.
	50.	The profound loss of function in the I2.62T-D2.63N double mutant suggests that, although these residues are not obligatory for agonist recognition, they play a synergistic and crucial role in modulating signal transduction.
	51.	Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus.
	52.	There was no evidence of association between schizophrenia and CNR1 (OR=0.97, 95% CI 0.82-1.13) or CHRNA7 (OR=1.07, 95% CI 0.77-1.49) genotypes, or of interactions between tobacco use and CHRNA7, or cannabis use and CNR1or COMT genotypes.
	53.	Analysis of promoter regions regulating basal and Il-4-inducible expression of CB1 in T-lymphocytes is reported.
	54.	CNR1 gene polymorphisms could be a psychopharmacogenetic rather than a vulnerability factor regarding schizophrenia and its treatment
	55.	Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)
	56.	Observational study of gene-disease association. (HuGE Navigator)
	57.	Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)
	58.	No significant difference was found between the schizophrenia and control cases in cannabinoid CB1 receptors binding in the superior temporal gyrus.
	59.	In major depression, CB(1) receptor immunopositive glial cells in the grey matter were decreased. Furthermore, our data show that different medications have an impact on the expression of CB(1) receptors in the ACC.
	60.	Impulsivity was significantly associated with the 6-repeat allele of the triplet repeat polymorphism (AATn/A6; p < .0001), as well as four SNPs in or near the CNR1 receptor gene.
	61.	In conclusion, we could not detect a statistically significant association between mutations in the CNR1 gene and the predisposition to develop schizophrenia.
	62.	Cannabinoid type 1 (CB1) receptors and their respective ligands, the endocannabinoids, have a significant role in the modulation of food intake and motivation to consume palatable food. [REVIEW]
	63.	There is no evidence for an association of CNR1 alleles with obesity in German children.
	64.	insulin may play a key role in the obesity-linked dysregulation of the adipose endocannabinoid system at the gene level
	65.	The endocannabinoid system is activated in obese visceral adipose tissue as shown by decreased FAAH, Cb1, and adiponectin expression.
	66.	G1422A polymorphism in the CNR1 gene is associated with increased abdominal adiposity in obese men.
	67.	CB1 cannabinoid receptor Helix 8 Leu contributes to selective signal transduction mechanisms
	68.	no association of human adipose tissue CNR1 mRNA expression with measures of body fat, metabolic parameters, fat cell function, or adiponectin expression.
	69.	CB(1)R and CB(2)R are differentially linked to lipid rafts, specialized microdomains of the plasma membrane--REVIEW
	70.	CB(1)-induced ERK activation was mediated by PI3K(IB) and this effect may have important consequences in the control of cell death/survival decision.
	71.	evidence that CB1 is able to potentiate an orexigenic receptor, OX1R
	72.	both mRNA for CB(1) and the corresponding protein are expressed in human prostate gland at level comparable with the receptor expressed in cerebellum; CB(1) preferentially expressed in prostate epithelia
	73.	delta(9)-THC induces an influx of extracellular calcium in resting T cells in a CB1- CB2- -dependent manner
	74.	upregulation of CB(1) receptors with concomitant increase in the CB(1) receptor-mediated [(35)S]GTPgammaS binding suggests a role for enhanced cannabinoidergic signaling in the prefrontal cortex of depressed suicides
	75.	apoptosis induced by cannabinoid receptor CB1 and CB2 agonists leads to activation of ERK1/2 leading to G1 cell cycle arrest in prostate cancer cells
	76.	Senile plaques in AD patients express CB1 receptors which show increased nitration. G-protein coupling and CB1 receptor protein expression are markedly decreased in AD brains.
	77.	A 5' Cnr1 "TAG" haplotype displays significant allelic frequency differences between substance abusers & controls in European-American, African-American & Japanese samples. Cnr1 genomic variation appears to play roles in human addiction vulnerability.
	78.	Genetic variants at CNR1 are associated with obesity-related phenotypes in men
	79.	results clearly suggest that Ser7.39, but not Ser2.60, plays a crucial role in mediating ligand specific interactions at the CB(1) receptor; modeling studies predict that Ser7.39 in a g-chi1 conformation may induce a helix bend in transmembrane helix 7
	80.	recombinant protein shows high potency with an endogenous capsaicin-like substance
	81.	dendritic cells were also found to express measurable amounts of CB1 and CB2 receptors and of FAAH. Cell maturation did not consistently modify the expression of these proteins
	82.	the presence of two long alleles in the cnr1 gene was associated with a reduced prevalence of depression in parkinson disease
	83.	the cannabinoid receptor CB1 was not identified in first trimester placenta
	84.	CB1 and CB2 immunoreactivity was observed in cutaneous nerve fiber bundles, mast cells, macrophages, epidermal keratinocytes, and the epithelial cells of hair follicles, sebocytes and eccrine sweat glands.
	85.	decreased thermal stability of T210I receptor & increased level of internalization of a T210I receptor-GFP chimera were also observed. Results suggest that T210 plays key role in governing transition between inactive & active CB(1) receptor states.
	86.	analysis of human cannabinoid receptor 1 truncation
	87.	High expression of CB1 receptor was observed in 29 (45%) in hepatocellular carcinoma.
	88.	Identification of a splice variant of the human CB1 receptor.
	89.	Results are the first report of an significant association between CB1 receptor and a subtype of schizophrenia.
	90.	a nigro-striatal lesion is associated with an increase in CB1 receptors in the basal ganglia in humans and nonhuman primates and that this increase could be reversed by chronic l-DOPA therapy.
	91.	Restricting AN and binging/purging AN may be associated with different alleles of the CNR1 gene coding cannabinoid receptor 1.
	92.	CB1 and CB2 receptor mRNA expression in human peripheral blood mononuclear cells (PBMC) from various donor types.
	93.	suggested that homozygous genotype CNR1 1359A/A confers vulnerability to alcohol withdrawal delirium.
	94.	CB1 plays a role in inhibiting neovascularization and skin neoplasm development
	95.	No convincing association is found for cannabinoid receptor type 1 (Cnr1) in a systematic genetic association study in a human sample of postmenopausal osteoporosis patients and matched female controls
	96.	In summary, up-regulation of CB1 in T lymphocytes in response to CBs themselves may facilitate or enhance the various immunomodulatory effects related to CBs.
	97.	CB(1) mRNA expression was negatively correlated with visceral fat mass, fasting insulin and circulating 2-arachidonylglycerol.
	98.	CB1 receptor expression throughout the different areas of the developing human brain suggests a specific role of the endocannabinoid system in the events related to human neural development.
	99.	Findings fail to replicate the original report of an association between SNPs adjacent to an alternative CNR1 exon 3 transcription start site and polysubstance abuse.
	100.	A common CNR1 haplotype is associated with developing fewer cannabis dependence symptoms among adolescents who have experimented with cannabis.
	101.	role of intracellular loops of cannabinoid CB1 receptor in functional interaction with Galpha16.
	102.	CB1 receptor mRNA expression was altered in Parkinson's disease and was affected by alterations in dopaminergic systems.
	103.	CB1R is associated with cholesterol- and sphyngolipid-enriched membrane domains (rafts).
	104.	associated with susceptibility to hebephrenic schizophrenia
	105.	High level of cannabinoid receptor 1 is associated with mantle cell lymphoma
	106.	homology model of the CB(1) cannabinoid receptor
	107.	CB(1) receptors are stabilized in a conformation that enables G(q)11 signaling by the WIN55212-2 cannabinoid agonist, thus shifting the G protein specificity of the receptor
	108.	study shows that CB1 receptors are upregulated in the liver of cirrhotic individuals and expressed in liver fibrogenic cells
	109.	results show that the presence of the CB1 polymorphic allele was significantly associated with a lower body mass index
	110.	Human sperm express functional CB(1)-R, the activation of which negatively influences important sperm functions such as motility.
	111.	lipid rafts control CB1R binding and signaling, and CB1R activation underlies the protective effect of methyl-beta-cyclodextrin against apoptosis
	112.	Sequential assignments of TM5 and intra-cellular loop 3 were accomplished. The obtained structure also showed alpha-helix in the TM5 region, but it was interrupted by a disordered region (Gly204_ILe206).
	113.	Antagonists may prove beneficial in the treatment of proliferative liver fibrosis.
	114.	lipid rafts control CB1R, but not CB2R, and endocannabinoid transport in immune and neuronal cells.
	115.	These data suggest that endocannabinoids regulate pathways affecting skeletal muscle oxidation, effects particularly evident in myotubes from obese individuals.
	116.	Tole of cysteine residues in CB1 ligand binding and activation, and demonstrate a method for mapping key determinants in CB1 structure and function
	117.	4 SNPs in the CNR1 gene are found to be positively associated with striatal response to happy faces (and not to disgust faces) in humans, using fMRI.

Submit: New GeneRIF Correction

[Top][Help]Interactions

Description ..........
Product	Interactant	Other Gene	Complex	Source	Pubs
HIST4H4 (histone H4) interacts with the CNR1 promoter.
NC_000006.9	NP_778224.1	HIST4H4		BIND	PubMed
An unspecified isoform of PAX3 interacts with the CNR1 promoter.
NC_000006.9		PAX3		BIND	PubMed
Pax3/FKHR interacts with the CNR1 promoter.
NC_000006.9	AAC50053.1			BIND	PubMed

NP_057167.1	NP_002059.1	GNA15		HPRD	PubMed

NP_057167.1	NP_002060.3	GNAI1		HPRD	PubMed

NP_057167.1	NP_002061.1	GNAI2		HPRD	PubMed

NP_057167.1	NP_006487.1	GNAI3		HPRD	PubMed

NP_057167.1	Hypocretin receptor 1	HCRTR1		HPRD	PubMed
Affinity Capture-Western
BioGRID:107668	BioGRID:109032	GNAI1		BioGRID	PubMed
Affinity Capture-Western
BioGRID:107668	BioGRID:109033	GNAI2		BioGRID	PubMed
Affinity Capture-Western
BioGRID:107668	BioGRID:109035	GNAI3		BioGRID	PubMed

[Top][Help]General gene information

Markers

RH70837(e-PCR): Links: UniSTS:57635

RH80958(e-PCR): Links: UniSTS:84004

NoName(e-PCR): Links: UniSTS:482606

NoName(e-PCR): Links: UniSTS:481334

D6S1243E(e-PCR): Links: UniSTS:151107

WI-19695(e-PCR): Links: UniSTS:70980

PMC193595P1(e-PCR): Links: UniSTS:271751

CNR1(e-PCR): Links: UniSTS:479925

RH79168(e-PCR): Links: UniSTS:66763

SHGC-35377(e-PCR): Links: UniSTS:40666

D6S1909(e-PCR): Links: UniSTS:24798

NoName(e-PCR): Links: UniSTS:482039

Genotypes

See CNR1 SNP Genotype Report

See CNR1 SNP Geneview Report

Homology

Homologs of the CNR1 gene The CNR1 gene is conserved in chimpanzee, dog, mouse, rat, chicken, and zebrafish.

Map Viewer (Mouse, Rat)

Pathways

KEGG pathway: Neuroactive ligand-receptor interaction: 04080
Reactome Event:Signaling by GPCR: REACT_14797

Gene Ontology Provided by GOA

Function	Evidence
cannabinoid receptor activity	TAS	PubMed
drug binding	IEA
receptor activity	IEA

Process	Evidence
G-protein signaling, coupled to cyclic nucleotide second messenger	TAS	PubMed
behavior	TAS	PubMed
signal transduction	IEA

Component	Evidence
integral to plasma membrane	TAS	PubMed
plasma membrane	TAS	PubMed

[Top][Help]General protein information

Preferred Names: cannabinoid receptor 1

Names: cannabinoid receptor 1; OTTHUMP00000016838; OTTHUMP00000016839; central cannabinoid receptor

[Top][Help]NCBI Reference Sequences (RefSeq)

RefSeqs maintained independently of Annotated Genomes

These reference sequences exist independently of genome builds. Explain

mRNA and Protein(s)

NM_001160226.1 → NP_001153698.1 cannabinoid receptor 1 isoform a

Description

Transcript Variant: This variant (3) contains an alternate exon in the 5' UTR, compared to variant 1. Variants 1, 3, 4, 5, and 6 all encode isoform a. This variant was designated CB1B by PubMed ID: 15289816.

Source sequence(s)

AL121835,AL136096

UniProtKB/TrEMBL

B2R9T4

UniProtKB/Swiss-Prot

P21554

Conserved Domains (1) summary

cl10458
Location:139 – 397
Blast Score: 428

7tm_1; 7 transmembrane receptor (rhodopsin family)
NM_001160258.1 → NP_001153730.1 cannabinoid receptor 1 isoform a

Description

Transcript Variant: This variant (4) contains two alternate exons in the 5' UTR, compared to variant 1. Variants 1, 3, 4, 5, and 6 all encode isoform a. This variant was designated CB1C by PubMed ID: 15289816.

Source sequence(s)

AL121835,AL136096

UniProtKB/TrEMBL

B2R9T4

UniProtKB/Swiss-Prot

P21554

Conserved Domains (1) summary

cl10458
Location:139 – 397
Blast Score: 428

7tm_1; 7 transmembrane receptor (rhodopsin family)
NM_001160259.1 → NP_001153731.1 cannabinoid receptor 1 isoform a

Description

Transcript Variant: This variant (5) uses a different splice site in the 5' UTR, compared to variant 1. Variants 1, 3, 4, 5, and 6 all encode isoform a. This variant was designated CB1D by PubMed ID: 15289816.

Source sequence(s)

AL121835,AL136096

UniProtKB/TrEMBL

B2R9T4

UniProtKB/Swiss-Prot

P21554

Conserved Domains (1) summary

cl10458
Location:139 – 397
Blast Score: 428

7tm_1; 7 transmembrane receptor (rhodopsin family)
NM_001160260.1 → NP_001153732.1 cannabinoid receptor 1 isoform a

Description

Transcript Variant: This variant (6) uses a different exon for its 5' UTR, compared to variant 1. Variants 1, 3, 4, 5, and 6 all encode isoform a. This variant was designated CB1E by PubMed ID: 15289816.

Source sequence(s)

AL136096

UniProtKB/TrEMBL

B2R9T4

UniProtKB/Swiss-Prot

P21554

Conserved Domains (1) summary

cl10458
Location:139 – 397
Blast Score: 428

7tm_1; 7 transmembrane receptor (rhodopsin family)
NM_016083.4 → NP_057167.2 cannabinoid receptor 1 isoform a

Description

Transcript Variant: This variant (1) represents the predominant transcript variant and it encodes the longer isoform (a). Variant 1 has also been called CB1A by PubMed ID: 15289816. Variants 1, 3, 4, 5, and 6 all encode isoform a.

Source sequence(s)

AL121835,BM682178,BX538191,DA128033,DA768458,X54937,X81120

Consensus CDS

CCDS5015.1

UniProtKB/TrEMBL

B2R9T4

UniProtKB/Swiss-Prot

P21554

Conserved Domains (1) summary

cl10458
Location:139 – 397
Blast Score: 428

7tm_1; 7 transmembrane receptor (rhodopsin family)
NM_033181.3 → NP_149421.2 cannabinoid receptor 1 isoform b

Description

Transcript Variant: This variant (2) lacks an internal segment near the 5' end of the coding region, compared to variant 1. The resulting protein (isoform b) has a shorter and distinct N-terminus compared to isoform a. PubMed ID: 15620723 referred to this variant and its protein as CB1b.

Source sequence(s)

AY766182,BM682178,BX538191,DA239984,DA793373,DA799263,X54937,X81120

Consensus CDS

CCDS5016.1

UniProtKB/Swiss-Prot

P21554

Conserved Domains (1) summary

cl10458
Location:106 – 364
Blast Score: 421

7tm_1; 7 transmembrane receptor (rhodopsin family)

RefSeqs of Annotated Genomes: Build 37.1

The following sections contain reference sequences that belong to a specific genome build. Explain

Genome Reference Consortium Human Build 37 (GRCh37), Primary_Assembly

Genomic

NC_000006.11

Range

88849582..88855055, complement

Download

GenBank FASTA Sequence Viewer (Graphics)
NT_007299.13

Range

26969416..26974889, complement

Download

GenBank FASTA Sequence Viewer (Graphics)

Alternate assembly (Celera)

Genomic

AC_000049.1

Range

89267474..89272947, complement

Download

GenBank FASTA Sequence Viewer (Graphics)
NW_923184.1

Range

21336078..21341551, complement

Download

GenBank FASTA Sequence Viewer (Graphics)

Alternate assembly (HuRef)

Genomic

AC_000138.1

Range

86064927..86070400, complement

Download

GenBank FASTA Sequence Viewer (Graphics)
NW_001838987.1

Range

18243129..18248602, complement

Download

GenBank FASTA Sequence Viewer (Graphics)

[Top][Help]Related Sequences

Nucleotide		Protein
genomic	AL136096.7	CAB96726.1
		CAI19916.1
genomic	AL136096.7	CAB96726.1
		CAI19916.1
genomic	AY011601.1	AAG37765.1
genomic	AY225225.1	AAO67710.1
genomic	CH471051.2	EAW48574.1
		EAW48575.1
		EAW48576.1
genomic	U73304.1	AAB18200.1
mRNA	AF107262.1	AAD34320.1
mRNA	AK313908.1	BAG36631.1
mRNA	AY766182.1	AAV35030.1
mRNA	AY995204.1	AAY21179.1
mRNA	BC074811.2	AAH74811.1
mRNA	BC074812.2	AAH74812.1
mRNA	BC095513.1	AAH95513.1
mRNA	BC100968.1	AAI00969.1
mRNA	BC100969.1	AAI00970.1
mRNA	BC100970.1	AAI00971.1
mRNA	BC100971.1	AAI00972.1
mRNA	BM682178.1	None
mRNA	BX538191.1	None
mRNA	DA128033.1	None
mRNA	DA239984.1	None
mRNA	DA768458.1	None
mRNA	DA793373.1	None
mRNA	DA799263.1	None
mRNA	DQ067455.1	AAY68486.1
mRNA	X54937.1	CAA38699.1
mRNA	X81120.1	CAA57018.1
mRNA	X81121.1	CAA57019.1

Protein Accession	Links
P21554.1	GenPept	UniProtKB/Swiss-Prot:P21554
Q506J9	GenPept	UniProtKB/TrEMBL:Q506J9
Q5JVL5	GenPept	UniProtKB/TrEMBL:Q5JVL5
Q9BYY6	GenPept	UniProtKB/TrEMBL:Q9BYY6